News Center

Home page

Peak Report

News reports

Draw lessons from accidents and implement management responsibilities

Release time:

2020-07-22

Draw Lessons from Accident Implement Management Responsibility

News from our newspaper 3# September 21# On the afternoon of 11th, Tianjiayi Chemical Co., Ltd., located in Xiangshui County Ecological Chemical Park, Jiangsu Province, exploded, causing heavy casualties. After the accident, the group company and relevant subordinate enterprises responded immediately and organized personnel to carry out relevant special inspection and hidden danger investigation.

The production process of each unit under the Group involves the use of hazardous chemicals by pharmaceutical companies and Jianfeng Health Technology Company. Peak health is mainly the use of alcohol for plant extraction, and pharmaceutical production enterprises in the production process of the use of more types of hazardous chemicals, in addition to flammable and explosive products, there are highly toxic chemicals.

3 22 , Jinxi Factory, Xinbeika and Zhongwang Pharmaceutical held special meetings respectively to report the accident and organize personnel to carry out safety hazard investigation, focusing on the integrity of equipment and facilities in hazardous chemicals production areas and storage areas (tank areas and warehouses), whether the safety operation procedures are sound and perfect, and whether the emergency facilities are in good condition.

Because of the characteristics of the pharmaceutical and health industry, pharmaceutical companies and Peak Health attach great importance to the management of hazardous chemicals. Peak Health has full-time safety officers to carry out safety inspections every day and upload production-related information to the provincial big data platform for risk prevention and control of hazardous chemicals. Safety education is provided to operators from time to time to ensure safe operation. When the Jinxi plant was built, it strictly followed the principle of three simultaneous construction of pollution prevention and control facilities and three simultaneous labor safety and health facilities. Safety and environmental protection facilities and equipment were designed, constructed and put into operation at the same time as the main project. Hazardous chemicals are stored, used and managed, and product licenses have been obtained; for hazardous waste materials, contracts are also signed with enterprises with relevant qualifications and entrusted for processing. The liquid hazardous chemicals of Zhongwang Pharmaceutical are stored in storage tanks outside the workshop. The solid hazardous chemicals are placed in Class A warehouse. The safety data sheets of all kinds of hazardous chemicals are placed near the hazardous chemicals warehouse to facilitate understanding of the characteristics. Safety facilities have combustible gas detectors, which will report to the police in time if they leak. When loading and unloading, a "tanker loading and unloading permit" shall be issued. When using, a picking list shall be issued, and the surplus shall be returned to the warehouse in time.

In response to the explosion accident, the group company also issued a notice requiring all units to closely follow the follow-up report of the accident, understand the cause of the accident in time, and carry out targeted prevention.

3 June 26 , the inspection team led by Chen Tianci, director of the group's safety management office, began to carry out special inspection and risk assessment of production safety within the scope of the company's production enterprises, to find dangerous sources at the production site, and to carry out inspection and risk assessment of hazardous operation sites, production, storage and use of hazardous chemicals.

Chen Tianci introduced that the company will conduct monthly safety inspections and regularly organize employee safety production education and training. The person in charge of the company and safety management personnel have relevant qualification certificates, have relevant emergency rescue plans, and organize drills from time to time., Regularly invite third-party units to conduct safety assessments on the plant. After the

3.21 incident, the group company requires each unit to take the lead in the leadership organization above the deputy general manager level, with technical, management backbone and safety management personnel to form an inspection team to focus on self-examination of enterprise safety management and hazard source risk assessment. Safety management includes the integrity, operability and control of safety rules and regulations, familiarity and implementation of safety operation procedures, safety education and training, and special operation management, the standardization of safety management ledger and other contents, hazard source risk assessment mainly focuses on hazardous processes, hazardous posts, production, storage and use of hazardous chemicals, and safety of special equipment to carry out inspection and risk assessment. The main accident types, trigger conditions, accident consequences, accident plans, etc. that may occur in each process are listed and analyzed according to the requirements of safe and controllable risk sources, complete and reliable facilities, and scientific operation specifications to form a self-assessment report.

At the same time, the group will also take this incident as an accident case, carry out publicity and education, analyze the subjective and objective causes of triggering the accident, carry out comparative inspection and risk assessment of hazard sources, do a good job in all aspects of hidden danger management, further deepen safety management, improve management ability and ensure normal and safe production of the company.

It is understood that in addition to the daily safety management work, New North Card will also strengthen the monitoring and inspection of chlorine, acrolein and acrylonitrile, and New North Card and Zhongwang Pharmaceutical are ready to install a "patrol" system on key parts and key devices to effectively implement the patrol inspection of key parts and key devices. Carry out relevant accident emergency drills to improve the emergency response capability of all factory employees. (Reporter

Ni Yingzhen)

More information

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-30

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Daye Jianfeng Cement Co., Ltd. Kiln End Flue Gas Desulfurization Project Completion Environmental Protection Acceptance Publicity

Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution

2020

07-31

Spike New Drug Approved for Registration

On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)

2020

07-31

Spike New Drug Approved for Registration

2020

07-31

< 1...30 31 32...61 > 跳转到页